Wuppertal's assay looks tighter. Does that make Levitra 5 mg a concentrated Viagra?
Wuppertal needed a cheap 5 or 20 mg carton, not a Viagra clone
Mark the city before the milligram. The Rhine bench built a binder. The carton later taught 5 or 20 mg as the labeled step pair.
Pfizer already owned the evening picture by 1998: swallow, wait about an hour, hope the plate was not a steak. Oral PDE5 blockade had a proof. What it did not have was a second patented structure. Bayer's Wuppertal group worked the same enzyme and landed on vardenafil, a rearranged core that sits tighter in the assay. Tighter grip shrank the labeled milligrams. It did not raise the erection ceiling.
People shopping a cheap Levitra 5 mg listing, or a 20 mg 'max' listing, often treat those numbers as personality. History treats them as administration. Ten milligrams was the recommended start, taken about sixty minutes before activity, once in any 24-hour stretch. Five was the labeled step down. Twenty was the labeled step up. The 2.5 mg chip existed for ugly CYP3A4 stories. It was never the public face of the carton.
A 2026 generic fill still counsels from that 2003 ladder. Brand Levitra faded. The Rhine chemistry did not. If a listing hides the QT card and sells only a milligram, it is selling a photo, not a dose point. The compound rows that still travel with the molecule sit on the vardenafil compound card.
Why the carton shows 5 or 20 mg next to a rhythm stamp
Five milligrams is the labeled down-step for men 65 and older, for moderate hepatic impairment (Child-Pugh B, with a 10 mg cap), and for a man already stable on an alpha-blocker. It is also the 24-hour cap when erythromycin or a mid-dose azole sits on the list. That is a clearance story. It is not a coupon strength.
Twenty milligrams is the labeled ceiling for an ordinary list when 10 mg works and side effects allow a climb. The carton stops there because the assay is tight, not because 20 mg is a dare. Head-to-head work never gave Bayer a harder-erection claim against sildenafil. Smaller milligrams reflect affinity. Nights do not rank by carton number.
Both chips inherit the same holds. Nitrates and nitrites stay forbidden. Riociguat stays off the path. Congenital long-QT and class IA or III antiarrhythmics stay on the avoid list. Shrinking from 20 to 5 does not wash those rows off. Growing from 5 to 20 does not invent them. The pair lives on one card.
May 2003 put milliseconds beside the milligram
May 2003 put milliseconds beside milligrams at the FDA Cardio-Renal meeting. Thorough QT work in healthy men found a small, dose-linked QTc stretch. At 10 mg the Fridericia-corrected interval moved about 8 milliseconds. At a supratherapeutic 80 mg it moved about 10. Moxifloxacin 400 mg, the positive control, sat in the same neighborhood. Absolute QT did not jump. The concentration slope was shallow.
The 80 mg arm was not a fantasy dose. It was chosen because that exposure covers what happens when a low 5 mg tablet sits next to ritonavir 600 mg twice daily, the ugliest 3A4 story on the insert. So the QT card and the 5 mg chip were already talking to each other in 2003. That conversation still belongs on a Portland blotter.
Sildenafil and tadalafil do not carry this row with the same force. That is why a Levitra folder without a rhythm line is a bad folder, even when the photo shows a 5 mg or a 20 mg tablet. Most men with a clean list and a normal heart never feel the stretch. Screen the medication list. Do not wire every first fill to a Holter. Trial numbers that sit next to the stamp live in the 5-20 mg endpoint review.
Co-promotion was a sales problem, not a chemistry problem
Bayer could synthesize a tablet in Germany. It could not, in 2003, field a US sales force sized to fight a household name. GSK distributed. Schering-Plough shared promotion. One film-coated object, three letterheads, because a household name already owned the evening. Logo history does not rewrite the swallow.
Tadalafil reached the US in November 2003. The class went from one oral PDE5 to three before anyone had a settled habit. Levitra was the second molecule the FDA cleared, after Viagra and before Cialis. At this desk it still reads as the third folder in the short-acting drawer once all three sat on the shelf. Compare clocks, not filing dates. Vardenafil and sildenafil share a planned evening window. Tadalafil keeps a long tail.
Contracts later shifted. Generics replaced the orange brand. A pharmacist handing over vardenafil 5 or 20 mg still marks nitrates, the 24-hour ceiling, the high-fat delay, and the QT list. Those rows outlived the cross on the old tablet.
Dates that still sit on a Wuppertal card
1998
Sildenafil proves oral PDE5 blockade works for erectile dysfunction and owns the evening picture.
Late 1990s
Bayer advances vardenafil in Wuppertal, a tighter PDE5 binder meant to be patentable, not a diamond copy.
May 2003
FDA Cardio-Renal advisory weighs the QT signal and still recommends approval.
August 19, 2003
Levitra film-coated tablets cleared; Bayer manufactures; GSK and Schering-Plough co-promote; the labeled pair includes 5 and 20 mg.
November 2003
Tadalafil reaches the US. Two short clocks and one long tail now share the class.
June 2010
Staxyn 10 mg orodispersible tablet approved. No 5 mg ODT. No 20 mg ODT. Not interchangeable with swallowed 10 mg.
2010s
Patents lapse. Generic vardenafil keeps the 2003 administration and the QT medication review.
These dates are not museum labels. They tell you which rules rode with the first film-coated carton and which arrived when a melt tablet showed up seven years later. The 5 or 20 mg pair is a 2003 object. Staxyn is a 2010 object with neither strength on the blister.
What 5 mg inherited that 20 mg still carries
Twenty milligrams did not invent a new safety file. Five milligrams did not retire one. Hepatic clearance, CYP3A4, nitrates, and the rhythm row travel with the molecule. Moderate impairment pulls the start to 5 mg and caps the climb at 10. Severe hepatic disease is a stop, not a smaller tablet. Ritonavir can demand 2.5 mg once every 72 hours because clearance collapses. That floor is real. It is not the SERP pair this page locks.
Alpha-blockers were a harder stop on the first insert than they later became. Early language treated the combination as unsafe even at low milligrams. Later labels eased that into a start-low caution, usually 5 mg, clocks separated, standing pressure watched on the first combined nights. Men still arrive with an old printout that forbids the pair entirely, or with a blog that pretends the pair is free. Both miss the current point.
Nitrates were never a maybe. Any PDE5 inhibitor plus a nitrate or nitrite can drop blood pressure to a dangerous level. Recreational nitrites count. The 2003 launch inherited that ban from sildenafil and stamped it again. A later calendar year does not loosen it. A 5 mg chip does not create a safe window. A 20 mg chip does not make the window wider.
Staxyn never joined the 5 or 20 mg pair
June 2010 added a melt tablet, Staxyn, 10 mg vardenafil on the tongue without water. The pitch was privacy at the table. The milligram did not change. Partial buccal absorption raised bioavailability versus the swallowed 10 mg film-coated tablet, so the two 10 mg objects are not milligram twins. You do not swap them to fine-tune a 5 mg or a 20 mg plan.
There is no 5 mg ODT. There is no 20 mg ODT. Men stabilized on a swallowed 5 mg step cannot melt their way into the same exposure. Men on 20 mg swallowed tablets cannot melt their way up. Phenylalanine in the ODT matters for phenylketonuria, a line easy to miss when the conversation is about not needing a glass.
Safety holds travel with the molecule. Nitrates stay forbidden. The QT list stays in force. Priapism and sudden vision or hearing loss still mean stop and seek care. Only the handling changes: dry mouth, no liquid with the dose, blister-to-tongue without splitting. History of the brand does not rewrite those rules.
Why a third short-acting PDE5 still sits on a Portland blotter
A third short clock did not raise the efficacy ceiling. It gave another side-effect shape and another monitoring row. Some men report fewer headaches or less visual tint than on sildenafil, likely from a slightly cleaner PDE5-over-PDE6 split. Those small differences decide adherence more often than any potency slide. The closest timing comparator remains sildenafil.
The rhythm caution is the other reason the folder exists. For a man on sotalol or with congenital long-QT, this is a reason to pick a different agent, not a reason to shrink to 5 mg and hope. For everyone else, choice after 2003 became timing, food sensitivity, nuisance effects, and cost once generics arrived. Who filed first is not a score.
Co-promotion ended. The counseling points did not. Dinner timing for the same pair lives in the light-plate 5 or 20 mg guide. A 2026 fill still opens with the 2003 card.
The point this origin folder still marks
Mark the rhythm row before anyone praises Wuppertal. Congenital long-QT, quinidine, procainamide, amiodarone, sotalol. Mark nitrates. Mark the 3A4 list. Dose only after those marks. Five milligrams is the labeled down-step. Twenty is the labeled ceiling. Ten remains the ordinary start the insert actually wrote.
Do not read a smaller milligram as a stronger night. Bayer sold potency. Trials sold equivalence. The useful history is administrative: planned short window, once per 24 hours, food that can slip the peak about an hour, a melt tablet that is a different object.
The point: Levitra 5 or 20 mg came from a Rhine need to put a patentable short clock on a US carton, stamped with a QT caution the class leader did not emphasize. If a listing hides that stamp, it is selling a photo of a tablet. Bring the list to your own clinician before anyone treats a search number as a starter.
Reader mail
Reader questions on this article
Answered by Dr. Priya Raman, PharmD · Clinical pharmacology & drug safety
Priya marks the Wuppertal QT card and the 5 or 20 mg pair. Mail is teaching, not a fill.
No. The assay explains why the carton tops out at 20 mg instead of 100. It does not rank hardness. IIEF and SEP in the labeled range sat next to sildenafil, not above it. I mark 5 mg when age, Child-Pugh B, a stable alpha-blocker, or a mid-strength 3A4 inhibitor makes 10 mg the wrong exposure. I do not mark it as a secret upgrade. Rows for the enzyme and the holds sit on the vardenafil compound card. Bring the full list to your own clinician before anyone treats a Rhine IC50 as a bedroom promise.
Nitroglycerin spray lives in my nightstand. Does a German origin story change the rule at 5 or 20 mg?
It does not. Combined cyclic GMP load from a nitrate plus any PDE5 inhibitor can drop pressure into a faint or worse. Spray, tablet, patch, and recreational nitrites all count. Wuppertal inherited that stop from the 1998 class leader and wrote it again in 2003. Five milligrams does not open a safe hour. Twenty milligrams does not either. Cardiology owns that conversation before anyone talks an ED tablet. Patient-facing pairing language: MedlinePlus.
Did the 2003 carton treat 20 mg as the usual first night, or was 5 mg the polite start?
Neither. The launch note set 10 mg about an hour before activity as the ordinary start, once in 24 hours. Twenty milligrams was the climb if 10 mg was timed and still thin. Five milligrams was the down-step for age, liver, alpha-blockers, and some 3A4 stories. A listing that sells 5 mg as the default Levitra night, or 20 mg as the only 'real' tablet, is selling the search pair. Your prescriber still has to mark which step applies.
I hate a glass at the table. Can I melt a 5 or 20 mg swallowed plan into Staxyn?
You cannot. Staxyn is a 2010 10 mg orodispersible tablet. Partial mouth absorption makes that 10 mg a different exposure than swallowed 10 mg. There is no 5 mg melt and no 20 mg melt. If you were stabilized on a film-coated step, stay on that object. Take the ODT dry. Keep nitrates and the QT list. Discretion is the only honest reason to ask for the melt. It is not a titration tool and it is not a dinner workaround.
The Cardio-Renal minutes mention about 8 milliseconds. Do I need a baseline ECG before a 5 mg fill?
Not if your list is clean and you have no congenital long-QT story. The thorough QT work showed a small QTc stretch, similar to the moxifloxacin control. The hard avoid is congenital long-QT or a class IA or III antiarrhythmic - quinidine, procainamide, amiodarone, sotalol. That is a list check. It is not a Holter wired to every first bottle. Background: heart.org. Five milligrams does not cancel the row. Twenty milligrams does not turn a normal heart into a veto.
Why did one Rhine tablet need GSK and Schering-Plough on the same carton?
Distribution. Bayer could make the tablet in Germany. Viagra already owned US awareness. Co-promotion put a second short-acting PDE5 in front of clinicians who had one habit. Logos later changed. Generics replaced the brand. The 5 or 20 mg pair, the 24-hour ceiling, and the QT review stayed. Company letterhead is a 2003 sales fact. It is not a counseling fact.
Big-box generic 20 mg - same QT card as the old orange Levitra?
Same active ingredient, same ladder, same administration, same holds. Price is the honest difference. Fill at a licensed pharmacy. Unregulated listings are a counterfeit risk - wrong milligrams, wrong powder. FDA label pages: fda.gov. Generic means the carton got cheaper. It does not mean the rhythm line was deleted. A Portland fill still opens the 2003 card.
I already do well on sildenafil. What does the Wuppertal folder add besides another brand?
Another short clock and a monitoring row the class leader does not emphasize the same way. If you want a planned evening, vardenafil or sildenafil. If you want a long tail, tadalafil. Nitrates rule out the class. Vardenafil adds the QT caution for a narrow subset and a labeled 5 or 20 mg step pair around a 10 mg start. Switch for tint, headache shape, or a formulary - not for a Rhine origin story. A balanced overview: Mayo Clinic. Your clinician still has to see the list I cannot see.
Child-Pugh B. Is 20 mg ever the Wuppertal-era answer, or is 5 mg the only honest chip?
Moderate impairment pulls the start to 5 mg and caps the climb at 10 mg. Twenty milligrams is not on that card. Severe hepatic disease is a stop, not a smaller tablet. Five milligrams also shows up with erythromycin and some mid-dose azoles. Liver numbers plus the drug list decide the step. Do not self-assign 5 or 20 mg because this origin note named the pair. Ask the clinician who has the labs.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated